A dual-monoclonal sandwich assay for prostate-specific membrane antigen: Levels in tissues, seminal fluid and urine

Prostate

Volumn 43, Issue 2, 2000, Pages 150-157

  Sokoloff, Roger ^a,b   Norton, K C ^a   Gasior, C L ^a   Marker, K M ^a   Grauer, L S ^a  

^a Hybritech Incorporated   (United States)

^b BECKMAN COULTER INC   (United States)

Author keywords

7E11; Immunoassay; Prostate cancer; Prostate specific membrane antigen (PSMA); Seminal fluid; Tissues; Urine

Indexed keywords

PROSTATE SPECIFIC MEMBRANE ANTIGEN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN URINE LEVEL; SEMEN ANALYSIS; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; HUMANS; MALE; METHODS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEMEN;

EID: 0034003421     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000501)43:2<150::AID-PROS10>3.0.CO;2-B     Document Type: Article

References (32)

1. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC. Comparison of digital rectal examination and serum prostate-specific antigen in the early detection or prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-1290.
2. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC, Scardino PT, Lange PH, Subong ENP, Parson RE, Gasior GH, Loveland KG, Southwick PC. Use of the Percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease. JAMA 1998;279:1542-1547.
3. Catalona WJ, Partin AW, Chan DW, Tindall DJ, Young CY-F, Klee GG, Darte C, Finlay JA, Rittenhouse HG, Wolfert RL, Woodrum DL. Detection of prostate cancer with %FPSA and hK2 when PSA is 2-4 ng/mL. J Urol 1999;161 Suppl 4:207.
4. Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1993;7:927-936.
5. Israeli RS, Powell CT, Fair WR, Heston WDW. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 1993;53:227-230.
6. Wright G, Haley C, Beckett ML, Schellhammer, PF. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol Oncol 1995;1:18-28.
7. Bostwick DG, Pacelli A, Blute M, Roche P, Murphy GP. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma. Cancer 1997;82:2256-2261.
8. Silver DA, Pellicer I, Fair WR, Heston WDW, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 1997;3:81-85.
9. Sweat SD, Pacelli A, Murphy GP, Bostwick DG. Prostate-specific membrane antigen expression is greatest in prostate adeoncarcinoma and lymph node metastases. Adult Urol 1998;52:1-4.
10. Troyer JK, Beckett ML, Wright GL. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J Cancer 1995;62:552-558.
11. Israeli RS, Powell CT, Corr JG, Fair WR, Heston WDW. Expression of the prostate-specific membrane antigen. Cancer Res 1994;54:1807-1811.
12. Rochon YP, Horoszewicz JS, Boynton AL, Holmes EH, Barren RJ, Erickson SJ, Kenny GM, Murphy GP. Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients. Prostate 1994;25:219-223.
13. Fair WR, Israeli RS, Heston WDW. Prostate-specific membrane antigen. Prostate 1997;32:140-148.
14. Gregorakis AK, Holmes EH, Murphy GP. Prostate-specific membrane antigen: current and future utility. Sem Urol Oncol 1998;16:2-12.
15. Murphy GP, Elgamal A-Z A, Su S, Bostwick DG, Holmes EH. Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen. Cancer 1998;8:2259-2269.
16. Troyer JK, Qi F, Beckett ML, Wright GL. Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen. Urol Oncol 1995;1:29-37.
17. Gretch DR, Suter M, Stinski MF. The use of biotinylated monoclonal antibodies and streptavidin-affinity chromatography to isolate herpes virus hydrophobic proteins or glycoproteins. Anal Biochem 1987;162:270-277.
18. Grauer LS, Lawler KD, Marignac JL, Kumar A, Goel AS, Wolfert RL. Identification, purification and subcellular localization of PSM' protein in the LNCaP prostatic carcinoma cell line. Cancer Res 1998;58:4787-4789.
19. Hemmila I, Dakubu S, Mukkala V-M, Siitari H, Lövgren T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 1984;137:335-343.
20. Instructions, AminoLink® Coupling Gel: Pierce Chemical Company.
21. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
22. Howard FD, Ledbetter JA, Mehdi SQ, Herzenberge LA. A rapid method for the detection of antibodies to cell surface antigens: A solid phase radioimmunoassay using cell membranes. J Immunol Methods 1980;38:75-84.
23. Liu H, Rajasekaran AK, Moy P, Xia Y, Kim S, Navarro V, Rahmati R, Bander NH. Constitutive and antibody induced internalization of prostate-specific membrane antigen. Cancer Res 1998;58:4055-4060.
24. Gala JL, Loric S, Brasseur, Delhez H, Heusterpreute M, Dumas F, Berteau P, Tombal B, Van Cangh P, Eschwege P, de Nayer P, Philippe M. PSMA expression in bladder cell carcinoma. J Urol 1998;159 Suppl 5:287.
25. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76:1899-1903.
26. Heston WDW. Characterization and glutamyl preferring carbocypeptidase function of prostate specific membrane antigen: A novel folate hydrolase. Urology 1997; 49 Suppl 3A:104-112.
27. Halsted CH, Ling E-h, Luthi-Carter R, Villanueva JA, Gardner JM, Coyle JT. Folylpoly-γ-glutamate carboxypeptidase from pig jejunum. J Biol Chem 1998;273:20417-20424.
28. Luthi-Carter R, Barczak AK, Speno H, Coyle JT. Molecular characterization of human brain N-acetylated α-linked acidic dipeptidase (NAALADase). J Pharmacology Exp Thera 1998;286: 1020-1025.
29. Diamandis EP, Yu H, Sutherland DJA. Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994;32:301-310.
30. Hsieh M-L, Charlesworth MC, Goodmanson M, Zhang S, Seay T, Klee GG, Tindall DJ, Young CYF. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Cancer Res 1997;57:2651-2656.
31. Pinto JT, Suffoletto BP, Berzin TM. Prostate-specific membrane antigen: A novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res 1996; 2:1445-1451.
32. Su SL, Huang I-P, Fair WR, Powell CT, Heston WDW. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res 1995;55:1441-1443.